Patient Recruitment/Retention Featured Articles
-
Future Challenges And Predictions For CGT Patient-Focused Solutions
10/4/2023
Leveraging innovative technologies to predict, model, and analyze data will enhance resource allocation, improve patient experience, reduce timelines, and drive cost efficiencies in the CGT industry.
-
Pfizer To Provide Individual Participant Data At Scale
9/21/2023
Historically, clinical trial participants have rarely gained possession of their individual trial data. But now, that's about to change. Pfizer is announcing plans to return individual data to its participants beginning this year.
-
Patients Are Speaking, And We Must Listen
9/7/2023
Maimah Karmo knows all too well the importance of speaking up for oneself. Here, the president and CEO of Tigerlily Foundation shares what drove her to create the nonprofit and why she won't stop advocating for patients.
-
What You Need To Know About The New ICH GCP E6(R3) Draft Guidelines
8/31/2023
The ICH’s updated draft guidelines for planning, designing, conducting, recording, and reporting clinical trials introduce a dynamic, risk-based approach to trial design and create universal standards for data.
-
What To Include In (And What To Leave Out Of) Your Clinical Trial Protocol
8/23/2023
To create a trial protocol that adequately captures your data requirements in a simple and streamlined fashion, consult early and often with patients and regulators to leverage their perspective.
-
How To Design A Clinical Trial Protocol With Patient And FDA Collaboration
8/18/2023
On a recent episode of Clinical Leader Live!, a panel of seasoned drug developers sat down to discuss the quintessential do’s and don’ts of modern clinical trials.
-
The Dos and Don’ts Of Patient Centricity
8/15/2023
New, exciting methodologies like DCTs and wearables can improve patient centricity, but only when participants’ lifestyles and preferences are kept in mind.
-
Recognizing Patients’ Wants And Needs Benefits Sponsors, Regulators, And, Of Course, Patients
8/11/2023
Most clinical trials fail to meet timelines, and the delay is typically caused by lagging patient enrollment. Patient advocates and consultants Richie Kahn and Jenn McNary say failed recruitment efforts often have to do with a fundamental mismatch between how a trial is designed and patients’ actual wants and needs.
-
Drug Development Must Meet Complex, Diverse Needs Of The Opioid Use Disorder Community
8/7/2023
With almost 80,000 opioid overdose deaths in 2022, the surge in opioid-related overdoses and deaths in the United States has continued at a relentless pace. Treatments are available, but with more diverse therapies and flexible trial designs, more patients will be able to begin their journey to recovery.
-
Improving Recruitment Through Community Engagement
8/1/2023
UPMC's Dr. Ken Ho shares personal insights about effective community engagement, which allowed him to increase recruitment in the Pitt Men's Study by 35% in just six months.